Commentary on “A case report of complete penoscrotal transposition and associated anomalies in a newborn” by Nsaho et al

Dear Editor, We read with great interest the article by Nsaho et al, titled “A case report of complete penoscrotal transposition and associated anomalies in a newborn”[1]. The authors should be commended for presenting a rare and intriguing congenital malformation and for emphasizing the importance of comprehensive neonatal examination. Complete penoscrotal transposition (PST) remains one of the least frequently encountered genital malformations, and each reported case contributes meaningfully to our collective understanding. Nevertheless, several important aspects merit further discussion and critical consideration. First, the report would have benefited from a more detailed embryological and developmental explanation of the anomaly. The discussion briefly mentions aberrant migration of the genital tubercle, yet does not fully address the complex sequence of events that may underlie complete versus incomplete transposition[2]. An expanded explanation such as integrating recent insights into molecular signaling pathways involved in genital differentiation, e.g., the role of SHH, BMP, and HOX genes would have significantly strengthened the pathophysiological context and educational value of the report[3]. Second, the diagnostic evaluation presented in the case appears limited. While the authors describe associated anomalies, the methodology for their detection is not fully elaborated. A detailed account of imaging modalities used (e.g., ultrasonography, echocardiography, genitourinary imaging, or karyotyping) would enhance the report’s completeness[4]. Given that complete PST often coexists with renal, cardiac, or skeletal malformations, omitting the diagnostic workflow leaves readers uncertain about the extent of systemic evaluation performed. Third, the surgical management plan and postoperative outcomes are described only briefly, leaving important clinical questions unanswered. The literature suggests that early, staged reconstruction such as involving scrotoplasty and urethral realignment can optimize both functional and cosmetic results. However, the authors do not specify the chosen surgical strategy, timing, or rationale, nor do they provide any follow-up data regarding urinary or reproductive outcomes[5]. Including even short-term postoperative observations would have markedly increased the clinical value and reproducibility of the report. Fourth, the genetic and prenatal diagnostic perspectives were not addressed. Given that PST may occur as part of syndromic patterns or chromosomal abnormalities, genetic testing would have provided insight into possible etiologic associations. Furthermore, the absence of prenatal imaging data limits understanding of whether this anomaly could have been detected antenatally. Such discussion would enhance the relevance of the report to obstetric and neonatal screening practices. Finally, the report could have more explicitly discussed the psychosocial and ethical implications of managing complex genital anomalies, particularly in cultural settings where gender-related anomalies may carry social stigma. Addressing parental counseling, ethical decision-making regarding surgical timing, and the importance of multidisciplinary management (including pediatric urology, genetics, and psychology) would have provided a more holistic understanding of patient care[6]. In summary, while Nsaho et al present a noteworthy and rare case of complete PST, the report is constrained by limited embryological analysis, incomplete diagnostic detail, and absence of postoperative or genetic information. Future reports would benefit from a more comprehensive multidisciplinary perspective, integration of advanced imaging and genetic evaluation, and longer follow-up to assess functional outcomes. Despite these limitations, this case serves as a valuable reminder of the importance of early recognition and coordinated care in managing complex congenital urogenital anomalies.